Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial. (2023)

First Author: Gorman EA
Attributed to:  A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202302-0297oc

PubMed Identifier: 37154608

Publication URI: http://europepmc.org/abstract/MED/37154608

Type: Journal Article/Review

Volume: 208

Parent Publication: American journal of respiratory and critical care medicine

Issue: 3

ISSN: 1073-449X